ars.els-cdn.com · web viewscaffold as novel cardiac myosin activators for the treatment of...

32
Supplementary Material-1 Exploration of flexible phenylpropylurea scaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickam a , Hitesh B. Jalani a , Thanigaimalai Pillaiyar a , Niti Sharma a , Pulla Reddy Boggu a , Eeda Venkateswararao a , Sun-Hee Woo a , You-Jung Lee b , Eun-Seok Jeon b , Sang-Hun Jung a * a College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, Korea b Division of Cardiology, Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul 06351, Korea *Corresponding author: [email protected] . Present address: College of Pharmacy and Institute of Drug Research and development, Chungnam National University, Daejeon, Korea Table of contents

Upload: others

Post on 22-Aug-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

Supplementary Material-1

Exploration of flexible phenylpropylurea scaffold as novel cardiac myosin activators for

the treatment of systolic heart failure

Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti Sharmaa, Pulla Reddy

Boggua, Eeda Venkateswararaoa, Sun-Hee Wooa, You-Jung Leeb, Eun-Seok Jeonb, Sang-Hun

Junga*

a College of Pharmacy and Institute of Drug Research and Development, Chungnam National

University, Daejeon 34134, Korea

b Division of Cardiology, Samsung Medical Center, Samsung Biomedical Research Institute,

Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul 06351, Korea

*Corresponding author: [email protected].

Present address: College of Pharmacy and Institute of Drug Research and development,

Chungnam National University, Daejeon, Korea

Table of contents

1. Copies of 1H NMR spectrum

2. Copies of 13C NMR spectrum

Page 2: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-Phenethyl-3-(3-phenylpropyl)urea (1)

Page 3: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of N-Phenethyl-5-phenylpentanamide (4)

Page 4: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(Benzyloxy)-3-phenethoxypropan-2-one (7)

Page 5: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-Phenyl-3-(3-phenylpropyl)urea (8)

Page 6: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-Benzyl-3-(3-phenylpropyl)urea (9)

Page 7: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1,3-Bis(3-phenylpropyl)urea (10)

Page 8: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-Cyclohexyl-3-(3-phenylpropyl)urea (11)

Page 9: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(Cyclohexylmethyl)-3-(3-phenylpropyl)urea (12)

1H and 13NMR of 1-(2-Cyclohexylethyl)-3-(3-phenylpropyl)urea (13)

Page 10: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(3-Phenylpropyl)-3-((tetrahydro-2H-pyran-4-yl)methyl)urea (14)

Page 11: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(3-Phenylpropyl)-3-(thiophen-2-ylmethyl)urea (15)

Page 12: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1-(Furan-2-ylmethyl)-3-(3-phenylpropyl)urea (16)

Page 13: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-((1H-indol-5-yl)methyl)-3-(3-phenylpropyl)urea (17)

Page 14: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(3-Phenylpropyl)-3-(2-(pyridine-2-yl)ethyl)urea (18)

Page 15: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(3-Phenylpropyl)-3-(2-(thiophen-2-yl)ethyl)urea (19)

Page 16: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(2-(Furan-2-yl)ethyl)-3-(3-phenylpropyl)urea (20)

Page 17: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(2-Morpholinoethyl)-3-(3-phenylpropyl)urea (21)

Page 18: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(2-Morpholinoethyl)-3-(4-phenylbutyl)urea (22)

Page 19: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(3-Cyclohexylpropyl)-3-phenethylurea (23)

Page 20: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(3-1H-Imidazol-1-yl)propyl)-3-phenethylurea (24)

Page 21: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(3-Morpholinopropyl)-3-phenethylurea (25)

Page 22: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(2-Cyclohexylethyl)-3-(3-cyclohexylpropyl)urea (26)

Page 23: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 2-Phenyl-N-(3-phenylpropyl)pyrrolidine-1-carboxamide (27)

Page 24: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 2-Phenyl-N-(3-phenylpropyl)piperidine-1-carboxamide (28)

Page 25: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 3-Phenyl-N-(3-phenylpropyl)piperidine-1-carboxamide (29)

Page 26: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1-(2,3-Dihydro-1H-inden-2-yl)-3-(3-phenylpropyl)urea (30)

Page 27: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of N-Phenethyl-4-phenylpiperidine-1-carboxamide (31)

Page 28: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of N-Phenethyl-4-phenylpiperazine-1-carboxamide (32)

Page 29: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti

1H and 13NMR of 1,3-Dimethyl-1-phenethyl-3-(3-phenylpropyl)urea (33)

Page 30: ars.els-cdn.com · Web viewscaffold as novel cardiac myosin activators for the treatment of systolic heart failure Manoj Manickama, Hitesh B. Jalania, Thanigaimalai Pillaiyara, Niti